PT99911A - Processo para a preparacao de 11beta-aril-4-estrenos modificados em posicao 6,7 e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de 11beta-aril-4-estrenos modificados em posicao 6,7 e de composicoes farmaceuticas que os contem

Info

Publication number
PT99911A
PT99911A PT99911A PT9991191A PT99911A PT 99911 A PT99911 A PT 99911A PT 99911 A PT99911 A PT 99911A PT 9991191 A PT9991191 A PT 9991191A PT 99911 A PT99911 A PT 99911A
Authority
PT
Portugal
Prior art keywords
pct
preparation
hydrogen atom
strenos
11beta
Prior art date
Application number
PT99911A
Other languages
English (en)
Other versions
PT99911B (pt
Inventor
Martin Schneider
Walter Elger
Eckhard Ottow
Krzysztof Chwalisz
Ulrike Fuhrmann
Wolfgang Sohwede
Arwed Cleve
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT99911A publication Critical patent/PT99911A/pt
Publication of PT99911B publication Critical patent/PT99911B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0092—Alkenyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
  • Photovoltaic Devices (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Holo Graphy (AREA)
  • Semiconductor Memories (AREA)
PT99911A 1990-12-22 1991-12-20 Processo para a preparacao de 11beta-aril-4-estrenos modificados em posicao 6,7 e de composicoes farmaceuticas que os contem PT99911B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4042007A DE4042007A1 (de) 1990-12-22 1990-12-22 6,7-modifizierte-11(beta)-aryl-4-estrene

Publications (2)

Publication Number Publication Date
PT99911A true PT99911A (pt) 1992-12-31
PT99911B PT99911B (pt) 1999-06-30

Family

ID=6421578

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99911A PT99911B (pt) 1990-12-22 1991-12-20 Processo para a preparacao de 11beta-aril-4-estrenos modificados em posicao 6,7 e de composicoes farmaceuticas que os contem

Country Status (16)

Country Link
US (1) US5843931A (pt)
EP (1) EP0565553B1 (pt)
JP (1) JP3181589B2 (pt)
CN (1) CN1065070A (pt)
AT (1) ATE182334T1 (pt)
AU (2) AU9098191A (pt)
CA (1) CA2099018A1 (pt)
DE (2) DE4042007A1 (pt)
FI (1) FI932874A0 (pt)
HU (1) HUT67311A (pt)
IE (1) IE914529A1 (pt)
IL (1) IL100465A (pt)
NO (1) NO932277L (pt)
PT (1) PT99911B (pt)
WO (1) WO1992011277A1 (pt)
ZA (1) ZA9110144B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3263112T3 (da) 2006-10-24 2020-08-17 Allergan Pharmaceuticals Int Ltd Sammensætninger og fremgangsmåder til undertrykkelse af endometriproliferationer
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
HUP0900487A2 (hu) * 2009-08-05 2011-03-28 Richter Gedeon Nyrt 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos polimorf módosulata és eljárás elõállítására
EP2550288A1 (en) 2010-03-22 2013-01-30 Repros Therapeutics Inc. Compositions and methods for non-toxic delivery of antiprogestins
US11110103B2 (en) 2015-12-23 2021-09-07 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
US11208432B2 (en) 2015-12-23 2021-12-28 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
US11124537B2 (en) 2015-12-23 2021-09-21 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
CN111690031B (zh) * 2016-10-07 2021-06-01 欧瑞克制药公司 糖皮质激素受体抑制剂
AU2019252561A1 (en) * 2018-04-11 2020-11-26 Oric Pharmaceuticals, Inc. Solid forms and formulations comprising a glucocorticoid receptor antagonist and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ214998A (en) * 1985-02-07 1989-06-28 Schering Ag 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions
DE3702383A1 (de) * 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
DE4018167A1 (de) * 1990-06-01 1991-12-05 Schering Ag Verfahren zur herstellung von 10(beta)-h-steroiden
DE4018168A1 (de) * 1990-06-01 1991-12-05 Schering Ag Ausgangsverbindungen fuer die herstellung von 10ss-h-steroiden und ein verfahren zur herstellung dieser ausgangsverbindungen

Also Published As

Publication number Publication date
IE914529A1 (en) 1992-07-01
NO932277D0 (no) 1993-06-21
CA2099018A1 (en) 1992-06-23
EP0565553B1 (de) 1999-07-21
ZA9110144B (en) 1992-10-28
PT99911B (pt) 1999-06-30
ATE182334T1 (de) 1999-08-15
AU3773395A (en) 1996-01-11
WO1992011277A1 (de) 1992-07-09
HUT67311A (en) 1995-03-28
JPH06505707A (ja) 1994-06-30
FI932874A (fi) 1993-06-21
NO932277L (no) 1993-08-20
AU9098191A (en) 1992-07-22
US5843931A (en) 1998-12-01
EP0565553A1 (de) 1993-10-20
IL100465A (en) 1997-03-18
FI932874A0 (fi) 1993-06-21
HU9301815D0 (en) 1993-09-28
JP3181589B2 (ja) 2001-07-03
DE59109142D1 (de) 1999-08-26
CN1065070A (zh) 1992-10-07
DE4042007A1 (de) 1992-06-25

Similar Documents

Publication Publication Date Title
ATE241990T1 (de) 3-beta-hydroxylierte natürliche steroidderivate enthaltende arzneimittelzusammensetzungen und ihre verwendung
IL111861A (en) Phenyl-n-substituted azabicycloalkene derivatives and pharmaceutical compositions containing them
AU645709B2 (en) New 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them
BR9407239A (pt) Azadioxacicloalquenos substituídos
ATE195740T1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
IL99775A0 (en) Antimicrobial agents containing substituted 2-cyclohexan-1-yl-amino derivatives,certain such novel compounds and their preparation
GR3018182T3 (en) Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and anticoagulant compositions comprising them.
DE69429173D1 (en) Taxolderivate
AU1220192A (en) Poly-4-aminopyrrole-2-carboxyamide derivatives, processes for their preparation and pharmaceutical compositions which contain them
PT99911A (pt) Processo para a preparacao de 11beta-aril-4-estrenos modificados em posicao 6,7 e de composicoes farmaceuticas que os contem
IL98262A0 (en) Chromone derivatives and pharmaceutical compositions containing them
GB9424766D0 (en) Pharmaceutical composition
PT99910A (pt) Processo para a preparacao de 14beta-h-, 14- e 15-eno-11beta-aril-4-estrenos e de composicoes farmaceuticas que os contem
PH24709A (en) Allylmercaptoacetylsydnonimines and pharmaceutical compositions thereof
HK1033455A1 (en) Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
DE60220779D1 (de) Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
NO20031444D0 (no) 17<alfa>-fluoralkylsteroider, metoder for fremstilling av disse, og farmasöytiske preparater inneholdende angitte forbindelser
ES8403109A1 (es) Un procedimiento para la preparacion de 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas.
SE8603589L (sv) Metylendioxifenantren- och stilbenderivat
DK0675895T3 (da) Etoposidderivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel og anvendelse deraf til fremstilling af et lægemiddel til anticancerbehandling
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
SE9203824D0 (sv) Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same
ATE173737T1 (de) 3-(aminoacyl-amino)-saccharide und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920814

FG3A Patent granted, date of granting

Effective date: 19990302

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000930